FRANKFURT (Reuters) -Weak domestic demand rather than U.S. tariffs is the main reason China is dumping surplus product on ...

This profile has not been claimed by the company. See reviews below to learn more or submit your own review. H&R Block is a tax preparation and financial services company that has been providing its ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of underlying ...

Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha ® ...

Reaffirms 2025 adjusted earnings guidance in the range of $4.00 to $4.20 per share, excluding merger-related costs, same as prior GAAP ...